A Professional & Personal Networking Site for all People related to Cardiology
HARTFORD, Conn.—A University of Connecticut researcher known for his work on red wine's benefits to cardiovascular health falsified his data in more than 100 instances, and nearly a dozen scientific journals are being warned of the potential…Continue
Started by Cardiology Network Team in Cardiology - General Forum. Last reply by DR. ALVI ABDUS SAMAD yesterday.
The U.S. Food and Drug Administration (FDA) is recommending limiting the use of the highest approved dose of the cholesterol-lowering medication, simvastatin (80 mg) because of increased risk of muscle damage. Simvastatin 80 mg should be used only…Continue
Started by Cardiology Network Team in Cardiology - General Forum. Last reply by DR. ALVI ABDUS SAMAD yesterday.
BackgroundOne quarter of strokes are of unknown cause, and subclinical atrial fibrillation may be a common etiologic factor. Pacemakers can detect subclinical episodes of rapid atrial rate, which correlate with electrocardiographically documented…Continue
Started by Cardiology Network Team in Cardiology - General Forum Jan 20.
Context Clinical practice guidelines recommend maintaining serum potassium levels between 4.0 and 5.0 mEq/L in patients with acute myocardial infarction (AMI). These guidelines are based on small studies that associated low potassium levels with…Continue
Started by Cardiology Network Team in Cardiology - General Forum Jan 20.
18 members
6 members
7 members
32 members
18 members
Added by DR. SATISH KUMAR
http://newmedia.ufm.edu/maniscalconanobacterium
Our principal cardiology investigator, Benedict Maniscalco, MD, FACC in a lecture on the development of…
ContinuePosted by Gary S. Mezo on January 23, 2012 at 6:40pm
Aims To compare the long-term outcome after percutaneous coronary intervention with ‘new-generation’ drug-eluting stents (n-DES) to ‘older generation’ DES (o-DES), and bare-metal stents…
Posted by Cardiology Network Team on January 20, 2012 at 12:48pm